MedTrace Logo

A Comparative Study of EMG Biofeedback and Pharmacotherapy for the Treatment of Masticatory Muscle Hyperactivity in Bruxism Patients

NCT06894472 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-03-25

No results posted yet for this study

Summary

This study examines the effect of electromyography biofeedback on masticatory muscles hyperactivity on patients with bruxism.

Conditions

  • Bruxism

Interventions

OTHER

Electromyography biofeedback

Participants in the experimental group will receive surface electromyography (SEMG) feedback training, targeting the Masseter muscle, for 40 minutes per session according to the Evidence-Based practice since longer practice may become counterproductive due to fatigue and loss of focus. The frequency of the sessions will be 3 sessions/week for 4 weeks.

DRUG

Pharmacotherapy

Pharmacotherapy will be received by all participants in the two groups in the form of multi relaxant (cyclobenzaprine) 10 MG twice daily for 4 weeks \& anti inflammatory (non steroidal anti-inflammatory drugs).

Sponsors & Collaborators

  • Beni-Suef University

    lead OTHER

Principal Investigators

  • Sara Abdullah mohamed elsamahy, PhD · Lecturer

  • Mohamed Farouk Abdel-Latif, PhD · Lecturer

  • Amal Ahmed Mohamed Morsi, PhD · Lecturer

  • Wafaa Atef Abd Allah, PhD · Lecturer

  • Myassar Ayman Amine, M.Sc · Ass. Lecturer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-26
Primary Completion
2025-04-26
Completion
2025-05-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06894472 on ClinicalTrials.gov